Provided by Tiger Fintech (Singapore) Pte. Ltd.

Femasys Inc

0.8839
-0.0529-5.65%
Post-market: 0.8800-0.0039-0.44%18:00 EDT
Volume:314.40K
Turnover:280.69K
Market Cap:28.75M
PE:-0.97
High:0.9400
Open:0.9400
Low:0.8600
Close:0.9368
Loading ...

Femasys Faces Nasdaq Noncompliance Notice for Stock Price

TIPRANKS
·
Yesterday

Femasys Inc. Faces Potential Delisting from Nasdaq Due to Noncompliance with Minimum Bid Price Requirement

Reuters
·
Yesterday

BRIEF-Femasys Files For Mixed Shelf Offering Of Up To $150 Million

Reuters
·
04 Jul

Femasys Inc. Enters Agreement to Sell Up to $10M in Shares to Alumni Capital LP

Reuters
·
04 Jul

Femasys Files for Mixed Shelf Offering of up to $150 Mln- SEC Filing

THOMSON REUTERS
·
04 Jul

Femasys Inc. Files Initial Statement of Beneficial Ownership for Chief Commercial Officer Nicholas Kelley Stinson

Reuters
·
02 Jul

Femasys Inc. Unveils Presentation Highlighting Innovations in Women's Reproductive Health and Strategic Focus Areas

Reuters
·
02 Jul

Femasys Gets Australia, New Zealand Approvals for Two Products

MT Newswires Live
·
01 Jul

Femasys Gains Regulatory Approvals in Australia and New Zealand

TIPRANKS
·
01 Jul

Femasys: Achieves Australian & New Zealand Regulatory Approvals for Femaseed for First-Line Infertility Treatment and Femvue Diagnostic

THOMSON REUTERS
·
01 Jul

Femasys Secures Regulatory Approvals in Australia and New Zealand for Groundbreaking Infertility Solutions FemaSeed and FemVue

Reuters
·
01 Jul

Femasys Gains Momentum with EU Approval and Strategic Partnerships, Justifying Buy Rating

TIPRANKS
·
29 Jun

Femasys Approves Director Elections and Share Increase

TIPRANKS
·
26 Jun

Femasys Inc. Conducted Annual Stockholders Meeting

Reuters
·
26 Jun

Femasys Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
26 Jun

Strategic Growth and Market Expansion: Femasys’s European Market Positioning and CE Mark Milestone

TIPRANKS
·
25 Jun

Femasys announces milestone with European approval of FemBloc

TIPRANKS
·
25 Jun

Femasys Announces Historic Milestone With European Approval of Fembloc®, the First Non-Surgical Permanent Birth Control

THOMSON REUTERS
·
25 Jun

Femasys Inc. Achieves European CE Mark Approval for FemBloc®, Pioneering Non-Surgical Permanent Birth Control Solution

Reuters
·
25 Jun

Femasys appoints Nicholas as CCO

TIPRANKS
·
17 Jun